Skip to main content
SpringerLink
Log in

Noncontraceptive hormone use and risk of breast cancer

  • Research Papers
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

All British Columbia (Canada) women under 75 years of age who were diagnosed with breast cancer during 1988–89 were asked to complete a postal questionnaire which included detailed information on menopausal estrogen use. Controls were drawn from the Provincial Voters List, matched by five-year age category to the cases. The present analysis consists of 699 cases and 685 controls who were postmenopausal due to natural causes or to a hysterectomy. There was no overall increase in risk of breast cancer associated with ever-use of unopposed estrogen (odds ratio [OR] = 1.0,95 percent confidence interval [CI] = 0.8–1.3). For estrogen use of 10 years or longer, the relative risk [RR] was 1.6 (CI = 1.1–2.5). The risk estimate for current users was somewhat elevated (OR = 1.4, CI = 1.0–2.0). Compared with women who never used hormone preparations, women who had used estrogen plus progestogen had an RR of 1.2 (CI = 0.6–2.2). Our results suggest that ever-use of estrogen, with or without progestogen, does not appreciably increase the risk of breast cancer. However, long-term and recent use of unopposed estrogen may be associated with a moderately increased risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Casagrande J, Gerkins V, Henderson BE, Mack T, Pike MC. Brief communication: Exogenous estrogens and breast cancer in women with natural menopause. JNCI 1976; 56: 839–41.

    Google Scholar 

  2. Hoover R, Gray LA, Cole P, MacMahon B. Menopausal estrogens and breast cancer. N Engl J Med 1976; 295: 401–5.

    Google Scholar 

  3. Startwell PE, Arthes FG, Tonascia JA. Exogenous hormones, reproductive history and breast cancer. JNCI 1977; 59: 1589–92.

    Google Scholar 

  4. Brinton LA, Williams RR, Hoover RN, et al. Breast cancer risk factors among screening program participants. JNCI 1979; 62: 37–44.

    Google Scholar 

  5. Ross RK, Paganini-Hill A, Gerkins VR, et al. A casecontrol study of menopausal estrogen therapy and breast cancer. JAMA 1980; 243: 1635–9.

    Google Scholar 

  6. Jick H, Walker AM, Watkins RN, et al. Replacement estrogens and breast cancer. Am J Epidemiol 1980; 112: 586–94.

    Google Scholar 

  7. Brinton LA, Hoover RN, Szklo M, et al. Menopausal estrogen use and risk of breast cancer. Cancer 1981; 47: 2517–22.

    Google Scholar 

  8. Kelsey JL, Fisher DB, Holford TR, et al. Exogenous estrogens and other factors in the epidemiology of breast cancer. JNCI 1981; 67: 327–33.

    Google Scholar 

  9. Hoover R, Glass A, Azevedo D, Milne K. Conjugated estrogens and breast cancer risk in women. JNCI 1981; 67: 815–20.

    Google Scholar 

  10. Lawson DH, Jick H, Hunter JR, et al. Exogenous estrogens and breast cancer. Am J Epidemiol 1981; 114: 710–13.

    Google Scholar 

  11. Hulka BS, Chambless LE, Deubner DC, et al. Breast cancer and estrogen replacement therapy. Am J Obstet Gynecol 1982; 143: 638–44.

    Google Scholar 

  12. Hiatt RA, Bawol R, Friedman GD, Hoover R. Exogenous estrogen and breast cancer after bilateral oophorectomy. Cancer 1984; 54: 139–44.

    Google Scholar 

  13. Kaufman DW, Miller DR, Rosenberg L, et al. Noncontraceptive estrogen use and the risk of breast cancer. JAMA 1984; 252: 63–7.

    Google Scholar 

  14. Brinton LA, Hoover R, Fraumeni JFJr. Menopausal estrogens and breast cancer risk: an expanded case-control study. Br J Cancer 1986; 54: 825–32.

    Google Scholar 

  15. La Vecchia C, Decarli A, Parazzini F, Gentile A, Liberati C, Franceschi S. Noncontraceptive oestrogens and the risk of breast cancer in women. Int J Cancer 1986; 38: 853–8.

    Google Scholar 

  16. McDonald JA, Weiss NS, Daling JR, Francis AM, Polissar L. Menopausal estrogen use and the risk of breast cancer. Breast Cancer Res Treat 1986; 7: 193–9.

    Google Scholar 

  17. Nomura AMY, Kolonel LN, Hirohata T, Lee J. The association of replacement estrogens with breast cancer. Int J Cancer 1986; 37: 49–53.

    Google Scholar 

  18. Buring JE, Hennekens CH, Lipnick RJ, et al. A prospective cohort study of postmenopausal hormone use and risk of breast cancer in US women. Am J Epidemiol 1987; 125: 939–47.

    Google Scholar 

  19. Hunt K, Vessey M, McPherson K, Coleman M. Longterm surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynecol 1987; 94: 620–35.

    Google Scholar 

  20. Wingo PA, Layde PM, Lee NC, Rubin G, Ory HW. The risk of breast cancer in postmenopausai women who have used estrogen replacement therapy. JAMA 1987; 257: 209–15.

    Google Scholar 

  21. Bergkvist L, Adami H-O, Persson I, Hoover R, Schairer C. The risk of breast cancer after estrogen and estrogenprogestin replacement. N Engl J Med 1989; 321: 293–7.

    Google Scholar 

  22. Thomas DB, Persing JP, Hutchinson WB. Exogenous estrogens and other risk factors for breast cancer in women with benign breast diseases. JNCI 1982; 69: 1017–23.

    Google Scholar 

  23. Rohan TE, McMichael AJ. Non-contraceptive exogenous oestrogen therapy and breast cancer. Med J Aust 1988; 148: 217–21.

    Google Scholar 

  24. Ewertz M. Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark. Int J Cancer 1988; 42: 832–8.

    Google Scholar 

  25. Dupont WD, Page DL, Rogers LW, et al. Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer 1989; 63: 948–57.

    Google Scholar 

  26. Mills PK, Beeson WL, Phillips RL, Fraser GE. Prospective study of exogenous hormone use and breast cancer in Seventh-day Adventists. Cancer 1989; 64: 591–7.

    Google Scholar 

  27. Colditz GA, Stampfer MJ, Willett WC, Hennekens CH, Rosner B, Speizer FE. Prospetive study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. JAMA 1990; 264: 2648–53.

    Google Scholar 

  28. Gambrell RDJr, Maier RC, Sanders BI. Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users. Obstet Gynecol 1983; 62: 435–43.

    Google Scholar 

  29. Nachtigall LE, Nachtigall RH, Nachtigall RD, Beckman EM. Estrogen replacement therapy. II. A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol 1979; 54: 74–9.

    Google Scholar 

  30. Kaufman DW, Palmer JR, Mouzon J, et al. Estrogen replacement therapy and the risk of breast cancer: results from the case-control surveillance study. Am J Epidemiol 1991; 134: 1375–85.

    Google Scholar 

  31. Palmer JR, Rosenberg, Clarke EA, et al. Breast cancer risk after estrogen replacement therapy; results from the Toronto breast cancer study. Am J Epidemiol 1991; 134: 1386–95.

    Google Scholar 

  32. Breslow NE, Day NE. Statistical Methods in Cancer Research Vol. 1. The Analysis of Case-control Studies. International Agency for Research on Cancer, 1980; Lyon, France: IARC Sci. Pub. No. 32: 192.

    Google Scholar 

  33. Dupont W, Page D. Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991; 151: 67–72.

    Google Scholar 

  34. Steinberg K, Thacker S, Smith S, et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991; 265: 1985–90.

    Google Scholar 

  35. Amstrong BK. Oestrogen therapy after menopause—boon or bane? Med J Aust. 1988; 148: 213–4.

    Google Scholar 

  36. Grady D, Ernster V. Invited commentary: Does postmenopausal hormone therapy cause breast cancer? Am J Epidemiol 1991; 134: 1396–400.

    Google Scholar 

  37. Voigt LF, Weiss NS, Chu J, Daling JR, McKnight B, Van Belle G, Progestogen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet 1991; 338: 274–77.

    Google Scholar 

  38. Gambrell RJr. Prevention of endometrial cancer with progestogens. Maturitas 1986; 8: 159–68.

    Google Scholar 

  39. Russo IH, Russo J. Hormone prevention of mammary carcinogenesis: a new approach in anticancer research. Anticancer Res 1988; 8: 1247–64.

    Google Scholar 

  40. Key TJA, Pike MC. The role of oestrogens and progestogens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988; 24: 29–43.

    Google Scholar 

  41. Ernster VL, Cummings SR. Progesterone and breast cancer. Obstet Gynecol 1986; 68: 715–7.

    Google Scholar 

  42. Spengler RF, Clarke EA, Woolever CA, et al. Exogenous estrogens and endometrial cancer: a case-control study and assessment of potential biases. Am J Epidemiol 1981; 114: 497–506.

    Google Scholar 

  43. Goodman MT, Nomura AMY, Wilkens LR, et al. Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol 1990; 131: 815–25.

    Google Scholar 

  44. Paganini-Hill A, Ross RK. Reliability of recall of drug usage and other health-related information. Am J Epidemiol 1982; 116: 114–22.

    Google Scholar 

  45. Persson I, Bergkvist L, Adami H-O. Reliability of women's histories of climacteric oestrogen treatment assessed by prescription forms. Int J Epidemiol 1987; 16: 222–8.

    Google Scholar 

Download references

Authors
  1. C. Paul Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janet R. Daling
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pierre R. Band
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Richard P. Gallagher
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Emily White
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Noel S. Weiss
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Drs Yang and Band, and Mr Gallagher are with the British Columbia Cancer Agency, Vancouver, Britsh Columbia, Canada. Authors are also affiliated with the School of Public Health and Community Medicine, University of Washington, Seattle, WA, USA (Drs Yang, Daling, White, and Weiss), and the Fred Hutchinson Cancer Research Center, Seattle, WA, USA (Drs Daling, White, and Weiss). Address correspondence to Mr Gallagher, Division of Epidemiology, Biometry and Occupational Oncology, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC, Canada, V5Z 4E6. This project is funded partially by Health and Welfare Canada, Grant #6610-1834-55 and by Workers Compensation Board of BC.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, C.P., Daling, J.R., Band, P.R. et al. Noncontraceptive hormone use and risk of breast cancer. Cancer Causes Control 3, 475–479 (1992). https://doi.org/10.1007/BF00051360

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00051360

Key words

Search

Navigation